CEACAM5 and neoplasm: HHQG can significantly decrease four tumor markers, including fetoprotein (AFP), A-L-fucoidase (AFU), R-glutamate transdermal enzyme (R-GT), and carcinoembryonic antigen (CEA) and reduce HBV-DNA, which indicates a lower cancer rate.